Psychosocial characteristics of patients undergoing cellular immunotherapies and their caregivers across time-Reference-Cited by-同舟云学术

Psychosocial characteristics of patients undergoing cellular immunotherapies and their caregivers across time

Published:2022-11-23 Issue:2 Volume:64 Page:364-370
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kirtane Kedar¹^ORCID,Reblin Maija²^ORCID,Oswald Laura B.³^ORCID,Irizarry-Arroyo Nathaly³,McCormick Rachael³^ORCID,Locke Frederick L.⁴^ORCID,Ketcher Dana⁵^ORCID

Affiliation:

1. Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA

2. Department of Family Medicine, University of Vermont, Burlington, VT, USA

3. Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA

4. Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA

5. University of Minnesota Medical School, Duluth Campus, MN, USA

Funder

ECOG-ACRIN

Federal Award

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2148216

Reference33 articles.

1. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

2. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

3. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

4. Mayer D. The survivorship tsunami: how will we be able to deliver psychosocial care to those in need. Paper presented at: 2018 American Psychosocial Oncology Society Annual Meeting; 2018.

5. Patient-Reported Outcomes with Chimeric Antigen Receptor T Cell Therapy: Challenges and Opportunities

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy;Transplantation and Cellular Therapy;2024-04